Latest News
Arix Bioscience plc: Aura Completes $40 Million Series D Financing


THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATION NO.596/2014
- Arix‘s total interest in Aura increases to £8.5 million from £3.9 million
- Arix commits $4.5 million (£3.4 million[1]) to increase its stake to 7.7%
- Proceeds to be used to support late stage clinical development; Phase 3 trial expected to start in H1 2020
Arix Bioscience plc (“Arix”) (LSE: ARIX) a global venture capital company focused on investing and building breakthrough biotech companies, today announces that it has committed $4.5 million (£3.4 million[1]) to the $40 million (£31 million) Series D financing (“the financing”) of Aura Biosciences (“Aura”), a leader in the development of novel targeted therapies in ocular oncology.
Following this commitment, Arix increases its stake to 7.7% on a fully diluted basis. Arix Investment Director Mark Chinwill continue to serve on the Aura Board. The financing recognised a 33% uplift in the book value of Arix’s Series C investment in Aura, with Arix’s total interest in Aura increasing to £8.5 million from £3.9 million on a fully committed basis.
Aura plans to use the proceeds from the Series D to support the late stage clinical development of its lead asset, light-activated AU-011, for the treatment of primary choroidal melanoma. The currently available treatments for choroidal melanoma come with the risk of severe vision loss and other long-term sequelae, especially for patients with melanomas located close to the fovea or optic disk. The ongoing Phase 1b/2 study with light-activated AU-011 has shown that the drug was well-tolerated, with clear evidence of tumor control and preservation of visual acuity at long term follow up, even in high risk patients. Aura has been granted Orphan Drug and Fast Track status from the U.S. Food & Drug Administration (FDA) and expects to initiate a registration trial in 2020.
Medicxi served as the lead new investor. In addition to Arix, Aura’s existing investors Lundbeckfonden Ventures, Advent Life Sciences, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments, Columbus Venture Partners, LI-COR Biosciences and several individual investors, including the estate of Henri Termeer, participated in the financing.
Joe Anderson, Chief Executive Officer of Arix, commented:
“Aura has made significant clinical progress with its lead candidate in development for primary choroidal melanoma, a rare and aggressive eye cancer, and is preparing for a Phase 3 study. We look forward to working alongside the world class management team and new and existing investors to accelerate development of this potential new treatment.”
Elisabet de los Pinos, Ph.D., Chief Executive Officer of Aura, commented:
“The additional funding provided by this Series D financing enables Aura to continue to execute on our goals of developing the first targeted treatment for patients with primary choroidal melanoma, a life and vision threatening rare disease with no drugs approved. We are delighted to have the continued support from Arix, and our new and existing investors, as we enter this next stage of growth for the Company.”
SOURCE Arix Bioscience plc
Latest News
Casino Kings Knocks Out Partnership with Boxing Powerhouse BoxNation

Two titans of entertainment are joining forces! UK-licensed casino and sportsbook, Casino Kings, and the legendary boxing platform, BoxNation, have announced a dynamic new partnership, set to deliver a knockout blow of exclusive content, promotions and responsible betting experiences for fans. Becoming their official boxing betting partner, Casino Kings is stepping into the ring with one of the most respected names in the fight game, promising fans a ringside seat to even better betting.
This isn’t just a bell ringing for another sponsorship deal; it’s a knockout partnership designed to bring you closer to the action than ever before. Casino Kings branding will be engrained into the boxing industry, prominent across BoxNation’s popular YouTube channel through branding and content, where the biggest names and personalities in boxing step into the spotlight for exclusive interviews.
For you savvy fight fans, Casino Kings will be rolling out a series of exclusive offers, adding even more thrill to 2025’s already-explosive boxing schedule. And here’s a great way to kick things off: Casino Kings is welcoming new members with a £35 Free Bet! Just deposit a minimum of £10 and place bets of £10 or more to grab yours. Don’t miss out!
Given BoxNation’s powerful presence in the boxing arena and Casino Kings’ reputation as a premier UK online casino and sports betting platform, this partnership is bound to be a knockout you won’t want to miss.
“We’re buzzing to partner with BoxNation—this really puts Casino Kings in the heart of the action.” Says Jack Dunn, COO of Casino Kings. “The team have been absolutely brilliant, and we’re excited to get stuck into some top-tier behind-the-scenes boxing content for the fans!”
“BoxNation is delighted to announce our partnership with Casino Kings. Casino Kings has a great reputation for delivering sports and entertainment options for users. We look forward to working together with Casino Kings to create a safe and enjoyable experience for fans.” adds Umar Ahmed, BoxNation Channel Lead.
Want to be the first to know? Follow Casino Kings and BoxNation on social media now for instant updates, special offers, and all the ringside action!
About BoxNation:
BoxNation is a dedicated boxing news and media outlet, providing fans exclusive interviews and behind the content featuring the boxing’s biggest names and personalities. With over 95k YouTube subscribers and 50 million plus views, BoxNation is delivering the best boxing content from all around the world. To find out more about BoxNation, visit: www.youtube.com/@BoxNationOfficial
About Casino Kings:
Casino Kings isn’t just another UK-licensed online casino and sportsbook – it’s a platform that puts player well-being first. Deeply committed to responsible gambling, they offer a secure environment equipped with robust tools to empower users to manage their play effectively. Beyond this dedication, Casino Kings delivers consistently fair and competitive odds across a thrilling selection of sports. Plus, the king casino team consistently provides their players with the best welcome bonuses, weekly promotions, daily offers, and much more!
Let’s keep the fun in the game. Please remember to gamble responsibly. 18+ only. For more information, visit: www.gambleaware.org.
Blockchain
India’s Fintech Market to Reach $990 Billion by 2032 at 30.2% CAGR – Fintech Firms Eye Untapped Indian Digital Payments Market with Secure, Low-Cost Digital Financial Solutions
Blockchain
Colb Asset SA Raises $7.3 Million in Oversubscribed Round to Bring Pre-IPO Giants to Blockchain
-
Blockchain Press Releases3 days ago
HTX Premieres USD1 Stablecoin Globally, Partnering with World Liberty Financial to Forge a New Era of Decentralized Economy
-
Blockchain2 days ago
Colb Asset SA Raises $7.3 Million in Oversubscribed Round to Bring Pre-IPO Giants to Blockchain
-
Blockchain6 days ago
UnitedStaking.com Launches Advanced Crypto Staking Platform with Global Reach and Real-World Impact
-
Blockchain Press Releases3 days ago
JuCoin made a global impact at TOKEN2049 Dubai, advancing its ecosystem with the “Peak Experience” vision and JuChain’s robust tech.
-
Blockchain2 days ago
Blocks & Headlines: Today in Blockchain – May 7, 2025 | Coinbase, Riot Games, Curve DAO, Litecoin, AR.IO
-
Blockchain Press Releases2 days ago
GRVT Launches Biggest Ever Trading Competition for Retail Traders, Offering Up to 175,000 USDT in Prizes
-
Blockchain Press Releases2 days ago
Cango Inc. Maintains Strong Mining Efficiency and Expands Bitcoin Holdings Amidst April Production Shift
-
Blockchain Press Releases1 day ago
HTX and Justin Sun Launch $6M Mars Program Special Edition, Offering One User a Historic Space Journey